ABSTRACT
The present invention relates to pharmaceutical composition comprising cinacalcet and its pharmaceutically acceptable salts and at least one or more pharmaceutically acceptable excipients, wherein the composition is free of binder. The present invention further relates to pharmaceutical composition of comp...
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
Documents
Directors report as per section 134(3)-09122020
List of share holders, debenture holders;-09122020
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-09122020
Form MGT-7-09122020_signed
Form AOC-4-09122020_signed
Form ADT-1-27112019_signed
Form AOC-4-27112019_signed
Form MGT-7-27112019_signed
Directors report as per section 134(3)-26112019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-26112019
Copy of written consent given by auditor-26112019
Copy of resolution passed by the company-26112019
List of share holders, debenture holders;-26112019
Form DPT-3-28062019
Auditor?s certificate-28062019
Form ADT-1-17042019_signed
Copy of written consent given by auditor-17042019
Copy of resolution passed by the company-17042019
Directors report as per section 134(3)-08122018
List of share holders, debenture holders;-08122018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-08122018
Form AOC-4-08122018_signed
Form MGT-7-08122018_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-24102017
Directors report as per section 134(3)-24102017
List of share holders, debenture holders;-24102017